Date Title Description PDF
25 Apr 2023 On business and financial situation ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) Download
21 Feb 2023 On business and financial situation The Company releases the press release related to the full year 2022 financial results. Download
21 Feb 2023 On business and financial situation The company releases the Integrated Report for the year 2022 Download
21 Feb 2023 About Corporate Governance The Company informs about the agreements adopted by the Board of Directors Download
21 Feb 2023 On business and financial situation The Company releases the full year 2022 financial results presentation. Download

Pages

Date Title Description PDF
08 May 2024 Announcement of General Shareholders’ Meeting The Company announces the decision of its Board of Directors to convene the Ordinary General Shareholders' Meeting Download
30 Apr 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 26 April and 30 April 2024 Download
26 Apr 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 19 April and 25 April 2024 Download
19 Apr 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 12 April and 18 April 2024 Download
12 Apr 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 5 April and 11 April 2024 Download

Pages

Date Title Description PDF
12 Jun 2013 Convocatorias y Acuerdos de Juntas y Asambleas Generales Download
06 Jun 2013 Otros sobre negocio y situación financiera Download
24 Apr 2013 Información sobre resultados (2) Download
24 Apr 2013 Información sobre resultados Download
24 Apr 2013 Convocatorias y Acuerdos de Juntas y Asambleas Generales Download

Pages